
PDS Biotech Reports First Quarter 2025 Financial Results And Provides Clinical Programs And Corporate Update
(MENAFN- GlobeNewsWire - Nasdaq) VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 a.m. Eastern Time …